 | • レポートコード：MRC2-11QY12240 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は病院治療グラム陰性菌感染症のグローバル市場について調査・分析したレポートです。種類別（クレブシエラ、アシネトバクター、コリ、セパシア、シュードモナス、セラチア、エンテロバクター、その他）市場規模、用途別（病院、研究室）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別病院治療グラム陰性菌感染症の競争状況、市場シェア ・世界の病院治療グラム陰性菌感染症市場：種類別市場規模 2015年-2020年（クレブシエラ、アシネトバクター、コリ、セパシア、シュードモナス、セラチア、エンテロバクター、その他） ・世界の病院治療グラム陰性菌感染症市場：種類別市場規模予測 2021年-2026年（クレブシエラ、アシネトバクター、コリ、セパシア、シュードモナス、セラチア、エンテロバクター、その他） ・世界の病院治療グラム陰性菌感染症市場：用途別市場規模 2015年-2020年（病院、研究室） ・世界の病院治療グラム陰性菌感染症市場：用途別市場規模予測 2021年-2026年（病院、研究室） ・北米の病院治療グラム陰性菌感染症市場分析：米国、カナダ ・ヨーロッパの病院治療グラム陰性菌感染症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの病院治療グラム陰性菌感染症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の病院治療グラム陰性菌感染症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの病院治療グラム陰性菌感染症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Pfizer、AstraZeneca、Abbott、Lupin Pharmaceuticals、Istituto lusofarmaco d’italia、Adelco S.A、Zhejiang yuntao biotechnology co., Ltd、Alcon Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of antimicrobials.
Market Analysis and Insights: Global Hospital-Treated Gram-Negative Infections Market
The global Hospital-Treated Gram-Negative Infections market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hospital-Treated Gram-Negative Infections Scope and Market Size
Hospital-Treated Gram-Negative Infections market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Treated Gram-Negative Infections market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Pfizer
AstraZeneca
Abbott
Lupin Pharmaceuticals
Istituto lusofarmaco d’italia
Adelco S.A
Zhejiang yuntao biotechnology co., Ltd
Alcon Laboratories
Market segment by Type, the product can be split into
Klebsiella
Acinetobacter
Coli
cepacia
Pseudomonas
Serratia
Enterobacter
Others
Market segment by Application, split into
Hospital
Lab
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital-Treated Gram-Negative Infections Revenue
1.4 Market by Type
1.4.1 Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Klebsiella
1.4.3 Acinetobacter
1.4.4 Coli
1.4.5 cepacia
1.4.6 Pseudomonas
1.4.7 Serratia
1.4.8 Enterobacter
1.4.9 Others
1.5 Market by Application
1.5.1 Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Lab
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Treated Gram-Negative Infections Market Perspective (2015-2026)
2.2 Global Hospital-Treated Gram-Negative Infections Growth Trends by Regions
2.2.1 Hospital-Treated Gram-Negative Infections Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital-Treated Gram-Negative Infections Historic Market Share by Regions (2015-2020)
2.2.3 Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital-Treated Gram-Negative Infections Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital-Treated Gram-Negative Infections Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Treated Gram-Negative Infections Players by Market Size
3.1.1 Global Top Hospital-Treated Gram-Negative Infections Players by Revenue (2015-2020)
3.1.2 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital-Treated Gram-Negative Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio
3.2.1 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital-Treated Gram-Negative Infections Revenue in 2019
3.3 Hospital-Treated Gram-Negative Infections Key Players Head office and Area Served
3.4 Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service
3.5 Date of Enter into Hospital-Treated Gram-Negative Infections Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital-Treated Gram-Negative Infections Historic Market Size by Type (2015-2020)
4.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
5.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
6.2 Hospital-Treated Gram-Negative Infections Key Players in North America (2019-2020)
6.3 North America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
6.4 North America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
7.2 Hospital-Treated Gram-Negative Infections Key Players in Europe (2019-2020)
7.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
7.4 Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
8 China
8.1 China Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
8.2 Hospital-Treated Gram-Negative Infections Key Players in China (2019-2020)
8.3 China Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
8.4 China Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
9.2 Hospital-Treated Gram-Negative Infections Key Players in Japan (2019-2020)
9.3 Japan Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
9.4 Japan Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
10.2 Hospital-Treated Gram-Negative Infections Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
11 India
11.1 India Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
11.2 Hospital-Treated Gram-Negative Infections Key Players in India (2019-2020)
11.3 India Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
11.4 India Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital-Treated Gram-Negative Infections Market Size (2015-2020)
12.2 Hospital-Treated Gram-Negative Infections Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020)
12.4 Central & South America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Hospital-Treated Gram-Negative Infections Introduction
13.1.4 Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Hospital-Treated Gram-Negative Infections Introduction
13.2.4 Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Hospital-Treated Gram-Negative Infections Introduction
13.3.4 AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Hospital-Treated Gram-Negative Infections Introduction
13.4.4 Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 Lupin Pharmaceuticals
13.5.1 Lupin Pharmaceuticals Company Details
13.5.2 Lupin Pharmaceuticals Business Overview
13.5.3 Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Introduction
13.5.4 Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.5.5 Lupin Pharmaceuticals Recent Development
13.6 Istituto lusofarmaco d’italia
13.6.1 Istituto lusofarmaco d’italia Company Details
13.6.2 Istituto lusofarmaco d’italia Business Overview
13.6.3 Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Introduction
13.6.4 Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.6.5 Istituto lusofarmaco d’italia Recent Development
13.7 Adelco S.A
13.7.1 Adelco S.A Company Details
13.7.2 Adelco S.A Business Overview
13.7.3 Adelco S.A Hospital-Treated Gram-Negative Infections Introduction
13.7.4 Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.7.5 Adelco S.A Recent Development
13.8 Zhejiang yuntao biotechnology co., Ltd
13.8.1 Zhejiang yuntao biotechnology co., Ltd Company Details
13.8.2 Zhejiang yuntao biotechnology co., Ltd Business Overview
13.8.3 Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Introduction
13.8.4 Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.8.5 Zhejiang yuntao biotechnology co., Ltd Recent Development
13.9 Alcon Laboratories
13.9.1 Alcon Laboratories Company Details
13.9.2 Alcon Laboratories Business Overview
13.9.3 Alcon Laboratories Hospital-Treated Gram-Negative Infections Introduction
13.9.4 Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)
13.9.5 Alcon Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital-Treated Gram-Negative Infections Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital-Treated Gram-Negative Infections Revenue
Table 3. Ranking of Global Top Hospital-Treated Gram-Negative Infections Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Klebsiella
Table 6. Key Players of Acinetobacter
Table 7. Key Players of Coli
Table 8. Key Players of cepacia
Table 9. Key Players of Pseudomonas
Table 10. Key Players of Serratia
Table 11. Key Players of Enterobacter
Table 12. Key Players of Others
Table 13. Global Hospital-Treated Gram-Negative Infections Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2015-2020)
Table 17. Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Hospital-Treated Gram-Negative Infections Market Growth Strategy
Table 23. Main Points Interviewed from Key Hospital-Treated Gram-Negative Infections Players
Table 24. Global Hospital-Treated Gram-Negative Infections Revenue by Players (2015-2020) (Million US$)
Table 25. Global Hospital-Treated Gram-Negative Infections Market Share by Players (2015-2020)
Table 26. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2019)
Table 27. Global Hospital-Treated Gram-Negative Infections by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service
Table 30. Date of Enter into Hospital-Treated Gram-Negative Infections Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 33. Global Hospital-Treated Gram-Negative Infections Market Size Share by Type (2015-2020)
Table 34. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2021-2026)
Table 35. Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2015-2020)
Table 36. Global Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 37. Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2021-2026)
Table 38. North America Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 40. North America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 41. North America Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 42. North America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 43. North America Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 44. Europe Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 46. Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 48. Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 50. China Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 51. China Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 52. China Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 53. China Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 54. China Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 55. China Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 56. Japan Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 58. Japan Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 60. Japan Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 64. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 66. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 68. India Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 69. India Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 70. India Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 71. India Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 72. India Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 73. India Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Hospital-Treated Gram-Negative Infections Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Hospital-Treated Gram-Negative Infections Market Share (2019-2020)
Table 76. Central & South America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020)
Table 78. Central & South America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020)
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Product
Table 98. Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 99. Abbott Recent Development
Table 100. Lupin Pharmaceuticals Company Details
Table 101. Lupin Pharmaceuticals Business Overview
Table 102. Lupin Pharmaceuticals Product
Table 103. Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 104. Lupin Pharmaceuticals Recent Development
Table 105. Istituto lusofarmaco d’italia Company Details
Table 106. Istituto lusofarmaco d’italia Business Overview
Table 107. Istituto lusofarmaco d’italia Product
Table 108. Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 109. Istituto lusofarmaco d’italia Recent Development
Table 110. Adelco S.A Company Details
Table 111. Adelco S.A Business Overview
Table 112. Adelco S.A Product
Table 113. Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 114. Adelco S.A Recent Development
Table 115. Zhejiang yuntao biotechnology co., Ltd Business Overview
Table 116. Zhejiang yuntao biotechnology co., Ltd Product
Table 117. Zhejiang yuntao biotechnology co., Ltd Company Details
Table 118. Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 119. Zhejiang yuntao biotechnology co., Ltd Recent Development
Table 120. Alcon Laboratories Company Details
Table 121. Alcon Laboratories Business Overview
Table 122. Alcon Laboratories Product
Table 123. Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (Million US$)
Table 124. Alcon Laboratories Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Treated Gram-Negative Infections Market Share by Type: 2020 VS 2026
Figure 2. Klebsiella Features
Figure 3. Acinetobacter Features
Figure 4. Coli Features
Figure 5. cepacia Features
Figure 6. Pseudomonas Features
Figure 7. Serratia Features
Figure 8. Enterobacter Features
Figure 9. Others Features
Figure 10. Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2020 VS 2026
Figure 11. Hospital Case Studies
Figure 12. Lab Case Studies
Figure 13. Hospital-Treated Gram-Negative Infections Report Years Considered
Figure 14. Global Hospital-Treated Gram-Negative Infections Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Hospital-Treated Gram-Negative Infections Market Share by Regions: 2020 VS 2026
Figure 16. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Hospital-Treated Gram-Negative Infections Market Share by Players in 2019
Figure 19. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Hospital-Treated Gram-Negative Infections Revenue in 2019
Figure 21. North America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…- トリプルネガティブ乳がん治療の世界市場（～2026年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Triple-Negative Breast Cancer Treat…
- 耐性緑膿菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Resistant Pseudomonas Aeruginosa Infections Drugs Market The global Resistant Pseudomonas Aeruginosa Infections Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Resistant Pseud…
- HER2陰性乳がん治療の世界市場（～2026年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
- 熱処理ガラスの世界市場（～2026年） Market Analysis and Insights: Global Heat Treated Glass Market The global Heat Treated Glass market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heat Treated Glass Scope and Market Size Heat Treated Glass market is segment…